144 related articles for article (PubMed ID: 2241314)
21. Pharmacokinetic analysis in intraperitoneal hyperthermic chemotherapy of far-advanced gastric cancer patients.
Kobayashi K; Fujimoto S; Shrestha RD; Kokubun M; Kikuchi S; Konno C; Ohta M; Takahashi M; Okui K
Gan No Rinsho; 1989 Aug; 35(9):1016-20. PubMed ID: 2504971
[TBL] [Abstract][Full Text] [Related]
22. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.
Fujimoto S; Takahashi M; Mutou T; Kobayashi K; Toyosawa T
Cancer; 1999 Feb; 85(3):529-34. PubMed ID: 10091726
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Pancreatoduodenectomy Plus Intraperitoneal Hyperthermic Perfusion on Resectable Pancreatic Head Cancer: Cohort Study.
Feng F; Cao X; Liu X; Qin J; Zhang S; Li Q; Liu J
Ann Surg Oncol; 2021 Apr; 28(4):2337-2345. PubMed ID: 32935266
[TBL] [Abstract][Full Text] [Related]
24. Prevention of scald injury on the peritoneo-serosal surface in advanced gastric cancer patients treated with intraperitoneal hyperthermic perfusion.
Fujimoto S; Kokubun M; Shrestha RD; Kobayashi K; Kiuchi S; Konno C; Takahashi M; Okui K
Int J Hyperthermia; 1991; 7(4):543-50. PubMed ID: 1919149
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion.
Kang LY; Mok KT; Liu SI; Tsai CC; Wang BW; Chen IS; Chen YC; Chang BM; Chou NH
J Chin Med Assoc; 2013 Aug; 76(8):425-31. PubMed ID: 23796652
[TBL] [Abstract][Full Text] [Related]
26. [Total body hyperthermia and continuous hyperthermic peritoneal perfusion as an adjuvant therapy in advanced gastric cancer].
Sugiyama Y; Suzuki H; Hada R; Miyagishima K; Yokoyama M; Daidouji K; Murata A; Yamazaki S; Mikami Y; Ozawa M
Gan To Kagaku Ryoho; 1991 Apr; 18(4):619-24. PubMed ID: 1901477
[TBL] [Abstract][Full Text] [Related]
27. [Hyperthermia adjunct to surgery in the treatment of scirrhous carcinoma of the stomach].
Kaibara N; Maeta M; Hamazoe R; Inoue Y; Koga S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1269-72. PubMed ID: 2837987
[TBL] [Abstract][Full Text] [Related]
28. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Canbay E; Mizumoto A; Ichinose M; Ishibashi H; Sako S; Hirano M; Takao N; Yonemura Y
Ann Surg Oncol; 2014 Apr; 21(4):1147-52. PubMed ID: 24356799
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
Murata S; Yamamoto H; Naitoh H; Yamaguchi T; Kaida S; Shimizu T; Shiomi H; Naka S; Tani T; Tani M
J Surg Oncol; 2017 Dec; 116(8):1159-1165. PubMed ID: 28743181
[TBL] [Abstract][Full Text] [Related]
30. [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].
Wei G; Fang GE; Bi JW; Shen XJ; Nie MM; Xue XC; Hua JD
Ai Zheng; 2005 Apr; 24(4):478-82. PubMed ID: 15820074
[TBL] [Abstract][Full Text] [Related]
31. [Stage IV Gastric Cancer with Positive Peritoneal Washing Cytology or Peritoneal Dissemination Was Successfully Treated with Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy(HIPEC)Followed by Systemic Chemotherapy - A Report of Two Cases].
Yamaguchi T; Murata S; Kaida S; Ohtake R; Takebayashi K; Yamamoto H; Miyake T; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Moritani S; Kushima R; Tani M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1954-1956. PubMed ID: 28133187
[TBL] [Abstract][Full Text] [Related]
32. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center.
Yang XJ; Li Y; Yonemura Y
J Surg Oncol; 2010 May; 101(6):457-64. PubMed ID: 20401915
[TBL] [Abstract][Full Text] [Related]
34. [Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis].
Mansvelt B; Bertrand C; Nockerman P; Arnould P; Delvaux P; Lechien X; de Neve de Roden A
Ann Chir; 1997; 51(1):60-7. PubMed ID: 9309889
[TBL] [Abstract][Full Text] [Related]
35. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal Lavage CEA mRNA Levels Predict Conversion Gastrectomy Outcomes after Induction Chemotherapy with Intraperitoneal Paclitaxel in Gastric Cancer Patients with Peritoneal Metastasis.
Yamaguchi H; Satoh Y; Ishigami H; Kurihara M; Yatomi Y; Kitayama J
Ann Surg Oncol; 2017 Oct; 24(11):3345-3352. PubMed ID: 28726078
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study.
Zhu ZG; Tang R; Yan M; Chen J; Yang QM; Li C; Yao XX; Zhang J; Yin HR; Lin YZ
Dig Surg; 2006; 23(1-2):93-102. PubMed ID: 16763374
[TBL] [Abstract][Full Text] [Related]
38. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
Samel S; Singal A; Becker H; Post S
Eur J Surg Oncol; 2000 Apr; 26(3):222-6. PubMed ID: 10753533
[TBL] [Abstract][Full Text] [Related]
39. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
40. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
